JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 48 filers reported holding JANUX THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $20,823,593 | -16.8% | 2,067,468 | -2.0% | 0.01% | -12.5% |
Q2 2023 | $25,031,210 | +10.7% | 2,109,338 | +12.9% | 0.02% | +6.7% |
Q1 2023 | $22,611,527 | -6.5% | 1,869,076 | +1.7% | 0.02% | -11.8% |
Q4 2022 | $24,173,460 | -9.0% | 1,837,791 | -53.1% | 0.02% | -15.0% |
Q3 2022 | $26,572,546 | +2.3% | 3,920,088 | +84.2% | 0.02% | +11.1% |
Q2 2022 | $25,966,000 | -22.6% | 2,127,797 | -9.0% | 0.02% | +12.5% |
Q1 2022 | $33,542,000 | -28.0% | 2,339,146 | -2.6% | 0.02% | -15.8% |
Q4 2021 | $46,558,000 | -9.4% | 2,400,893 | -0.6% | 0.02% | -13.6% |
Q3 2021 | $51,375,000 | -20.4% | 2,416,404 | -9.4% | 0.02% | -21.4% |
Q2 2021 | $64,522,000 | – | 2,668,207 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 8,670,644 | $187,546,000 | 2.60% |
5AM Venture Management, LLC | 446,266 | $9,653,000 | 1.96% |
Samsara BioCapital, LLC | 411,871 | $8,909,000 | 1.40% |
EcoR1 Capital, LLC | 1,411,975 | $30,541,000 | 1.06% |
BVF INC/IL | 1,017,314 | $22,005,000 | 0.86% |
Orbimed Advisors | 3,466,386 | $74,978,000 | 0.82% |
Logos Global Management LP | 247,122 | $4,811,000 | 0.35% |
Woodline Partners LP | 300,031 | $6,490,000 | 0.11% |
Parkwood LLC | 20,777 | $449,000 | 0.05% |
JANUS HENDERSON GROUP PLC | 2,416,404 | $51,375,000 | 0.02% |